Synthesis of Celecoxib-Eutectic Mixture Particles via Supercritical CO

adipic acid celecoxib eutectic mixture quality by design saccharin spray drying supercritical fluid

Journal

Pharmaceutics
ISSN: 1999-4923
Titre abrégé: Pharmaceutics
Pays: Switzerland
ID NLM: 101534003

Informations de publication

Date de publication:
26 Jul 2022
Historique:
received: 30 05 2022
revised: 15 07 2022
accepted: 18 07 2022
entrez: 27 7 2022
pubmed: 28 7 2022
medline: 28 7 2022
Statut: epublish

Résumé

Significant improvements in the wettability and dissolution rate of celecoxib (CEL), a poorly soluble selective cyclooxygenase-2 (COX-2) inhibitor, have been shown by Huyn et al., 2019 by combining the binary pharmaceutical compositions including CEL and one of the two co-formers, adipic acid (ADI) and saccharin (SAC), into eutectic mixtures (EM).

Identifiants

pubmed: 35893805
pii: pharmaceutics14081549
doi: 10.3390/pharmaceutics14081549
pmc: PMC9331714
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : National Research Foundation of Korea
ID : NRF-2021R1A2C2008834
Organisme : National Research Foundation of Korea
ID : 2018R1A6A1A03023718

Références

Drug Discov Today. 2007 Dec;12(23-24):1068-75
pubmed: 18061887
Int J Pharm. 2022 Apr 5;617:121557
pubmed: 35134481
Eur J Pharm Biopharm. 2000 Jul;50(1):47-60
pubmed: 10840192
J Phys Chem B. 2010 Oct 14;114(40):12792-801
pubmed: 20849135
Int J Pharm. 2010 Aug 30;396(1-2):239-45
pubmed: 20599602
AAPS J. 2017 Nov;19(6):1537-1549
pubmed: 28831727
Int J Nanomedicine. 2012;7:5733-44
pubmed: 23166438
JAMA. 2000 Sep 13;284(10):1247-55
pubmed: 10979111
Cell Biosci. 2013 Feb 06;3(1):8
pubmed: 23388178
Int J Pharm. 2019 Jan 10;554:61-71
pubmed: 30347274
Int J Pharm. 2010 Sep 15;397(1-2):211-7
pubmed: 20637272
Int J Pharm. 2008 Jul 9;359(1-2):211-9
pubmed: 18501538
Int J Pharm. 2020 Jul 30;585:119489
pubmed: 32522504
J Pharm Sci. 2014 Feb;103(2):527-38
pubmed: 24375069
Annu Rev Chem Biomol Eng. 2021 Jun 7;12:217-240
pubmed: 33781083
Asian J Pharm Sci. 2017 Jan;12(1):1-8
pubmed: 32104308
AAPS J. 2014 Jul;16(4):771-83
pubmed: 24854893
J Control Release. 1998 Jan 2;50(1-3):297-308
pubmed: 9685897
J Pharmacol Exp Ther. 2001 May;297(2):638-45
pubmed: 11303053
Drugs. 2000 Apr;59(4):957-80
pubmed: 10804043

Auteurs

Seung-Hyeon Hong (SH)

College of Pharmacy, Yonsei University, 85 Songdogwahak-ro, Yeonsu-gu, Incheon 21983, Korea.
Yonsei Institute of Pharmaceutical Sciences, Yonsei University, 85 Songdogwahak-ro, Yeonsu-gu, Incheon 21983, Korea.

Linh Dinh (L)

College of Pharmacy, Yonsei University, 85 Songdogwahak-ro, Yeonsu-gu, Incheon 21983, Korea.
Yonsei Institute of Pharmaceutical Sciences, Yonsei University, 85 Songdogwahak-ro, Yeonsu-gu, Incheon 21983, Korea.

Sharif Md Abuzar (SM)

College of Pharmacy, Yonsei University, 85 Songdogwahak-ro, Yeonsu-gu, Incheon 21983, Korea.
Yonsei Institute of Pharmaceutical Sciences, Yonsei University, 85 Songdogwahak-ro, Yeonsu-gu, Incheon 21983, Korea.

Eun Seok Lee (ES)

College of Pharmacy, Yonsei University, 85 Songdogwahak-ro, Yeonsu-gu, Incheon 21983, Korea.
Yonsei Institute of Pharmaceutical Sciences, Yonsei University, 85 Songdogwahak-ro, Yeonsu-gu, Incheon 21983, Korea.

Sung-Joo Hwang (SJ)

College of Pharmacy, Yonsei University, 85 Songdogwahak-ro, Yeonsu-gu, Incheon 21983, Korea.
Yonsei Institute of Pharmaceutical Sciences, Yonsei University, 85 Songdogwahak-ro, Yeonsu-gu, Incheon 21983, Korea.

Classifications MeSH